Director, Medical Education & Scientific Communications

Genetix Biotherapeutics•Somerville, MA

2d•Hybrid

About The Position

The Director of Medical Education & Scientific Communication will design, lead, and scale our global medical education strategy and scientific communications for cell‑based gene therapies addressing hemoglobinopathies. This leader will develop the company’s scientific narrative, ensure medical accuracy and balance across all channels, and equip healthcare professionals (HCPs), payer audiences, and patient communities with timely, evidence‑based information. The role spans strategy through execution—publication planning, congress activities, omnichannel medical education, and cross‑functional content governance—grounded in ethical standards and compliance.

Requirements

MD, PharmD, PhD, or MS in a biomedical field; experience in hematology or cell and gene therapy strongly preferred.
8+ years in Medical Affairs/Scientific Communications within biopharma, including publication planning and medical education leadership.
Deep understanding of hemoglobinopathies (SCD, β‑thalassemia), cell‑based gene therapy modalities, safety monitoring (including long‑term follow‑up), and registry/RWE considerations.
Experience building omnichannel education programs.
Fluency with compliance frameworks (GPP, ICMJE, ACCME, OIG, PhRMA Code) and medical review processes.
Exceptional scientific writing, editorial judgment, and stakeholder management; comfortable engaging with KOLs, investigators, and advocacy leaders.

Nice To Haves

Scientific Rigor & Clarity: Translates complex gene therapy data into balanced, audience‑appropriate narratives.
Strategic Acumen: Connects education plans to clinical milestones, access needs, and the evolving competitive landscape.
Entrepreneurial Agility: Willingness and ability to do hands on work and produce content while setting a vision for team expansion and identifying and leading external vendors, as needed
Operational Excellence: Scales processes, platforms, and SOPs for quality, compliance, and speed.
Influence & Collaboration: Builds trust across clinical, regulatory, market access, and field teams.
Inclusion & Cultural Competence: Designs education that respects diverse backgrounds and health literacy.

Responsibilities

Build a 1–3-year medical education roadmap aligned to clinical development and lifecycle plans.
Analyze field and inbound insights to inform educational priorities
Design non‑promotional education for multidisciplinary audiences (hematology, BMT/transplant, apheresis, transfusion medicine, genetic counseling, nursing), including webinars, symposia, workshops, and digital learning modules.
Establish content measurement frameworks (reach, engagement, knowledge lift, practice intent) and continuous improvement loops.
Lead end-to-end publication planning (abstracts, posters, oral presentations, manuscripts, review articles, plain-language summaries) across clinical, translational, and real-world evidence.
Chair or support publication steering committees; ensure adherence to GPP (Good Publication Practice), ICMJE authorship criteria, data transparency, and fair balance.
Maintain the enterprise scientific lexicon and core claims matrix; ensure consistency across materials and channels.
Lead or co‑lead medical review for scientific materials; partner with Legal/Compliance/Regulatory on clear SOPs and guardrails.
Implement a scalable content operating model (templates, style guides, plain‑language standards, accessibility) and a robust medical approvals workflow.
Collaborate within Medical Affairs and with Clinical Development, Regulatory, Pharmacovigilance, Commercial, Market Access, and Patient Advocacy to ensure accuracy and balance across communications.
Develop and deliver scientific training programs for internal teams (e.g., onboarding for MSLs/field medical; refresher modules on gene therapy mechanisms, safety monitoring, LTFU requirements).
Own Med Affairs content and define KPIs, dashboards, and reporting cadence.
Pilot innovative formats (micro‑learning, interactive pathways, patient‑friendly visuals) and ensure accessibility for diverse audiences.